The expression of ITM2A induced G2/M cell cycle arrest and inhibited ovarian cancer cell growth by decreasing the expression of cyclin B1, p-CDC2, CDC2, and CDC25C [47]. The gene discussed is ITM2A; the disease is ovarian carcinoma.